Soluble receptor for advanced glycation end products as a biomarker of symptomatic vasospasm in subarachnoid hemorrhage.
CONCLUSIONS: Plasma sRAGE levels can be used as a potential biomarker for predicting SVS after SAH.
PMID: 31675694 [PubMed - as supplied by publisher]
Source: Journal of Neurosurgery - Category: Neurosurgery Authors: Aida Y, Kamide T, Ishii H, Kitao Y, Uchiyama N, Nakada M, Hori O Tags: J Neurosurg Source Type: research
More News: Brain | Hemorrhagic Stroke | Ischemic Stroke | Neurology | Neurosurgery | Stroke | Study | Subarachnoid Hemorrhage